Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

General Investigation for PAXLOVID PAC

NCT05263908 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT05263908
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05263908 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
General Investigation for PAXLOVID PAC
Lead sponsor
Pfizer
Phase
Observational
Overall status
Completed
Start date
March 31, 2022
Completion date
July 10, 2023
Enrollment
3,346 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

sars-cov-2 infection